Transthyretin Amyloid Cardiomyopathy Risk Evaluation in a Cohort of Patients With Heart Failure

INTRODUCTION: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive, infiltrative form of heart failure (HF). Nevertheless, ATTR-CM is a largely underrecognized and misdiagnosed condition. This study’s objective was to develop an efficient model to assess the chance of ATTR-CM in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, Angie A, Shaw, Paul B, Jeong, Mark Y, Olson, Kari L, Delate, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Permanente Federation 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266840/
https://www.ncbi.nlm.nih.gov/pubmed/36970848
http://dx.doi.org/10.7812/TPP/22.135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266840/
https://www.ncbi.nlm.nih.gov/pubmed/36970848
http://dx.doi.org/10.7812/TPP/22.135

Ejemplares similares